Related Experiment Video
Updated: Jan 17, 2026

Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions
Published on: December 20, 2017
His-tagged pro-apoptotic peptides: enhancing cell internalization and anticancer effect in vitro
Aldo O González-Cruz1, José Juan Pérez-Trujillo2, Isaías Balderas-Rentería1
1Laboratorio de Farmacología Molecular y Modelos Biológicos, Facultad de Ciencias Químicas, Universidad Autonoma de Nuevo Leon (UANL), Av. Guerrero S/N, Colonia Treviño, CP 64570, Monterrey, Nuevo León, Mexico.
Abstract:
Epidermal growth factor receptor (EGFR) overexpression is commonly found in various solid tumors, including non-small cell lung cancer, where it is associated with poor prognosis and resistance to treatment. Despite the availability of EGFR-targeted therapies, overcoming drug resistance remains a challenge. Tumor-homing cell-penetrating peptides can selectively target cancer cells and improve drug delivery. In this study, we evaluated the anticancer potential of EGFR-targeted pro-apoptotic peptides, specifically NRPD-KLAK-H and NRPD-CTMP4-H, designed to enhance internalization and overcome drug resistance in EGFR-positive cancers, and compared their effects with those of the free His-tagged peptides NRPD-H, KLAK-H, and CTMP4-H. MTT assays showed that KLAK-H and NRPD-KLAK-H exhibited the strongest anticancer effects, significantly inhibiting cell growth in A-549 cell line, with IC50 values of 33.3 µM and 40.9 µM, respectively. TUNEL assays suggested that KLAK-H and NRPD-KLAK-H induced apoptosis in the tested cell lines. Immunofluorescence revealed successful internalization of KLAK-H/NRPD-KLAK-H, but poor uptake of CTMP4-H/NRPD-CTMP4-H. The His-tag modification improved peptide internalization, suggesting that short poly-histidine sequences can enhance cellular uptake of pro-apoptotic KLAK-derived peptides, particularly in cancer cells. Although the proposed EGFR-targeted proapoptotic peptides did not show the expected effect, our findings indicate that His-tagged pro-apoptotic peptides, especially KLAK-H, hold promise as potential cancer treatments.
Insights
His-tagged pro-apoptotic peptides, particularly KLAK-H, show promise for cancer treatment by enhancing cellular uptake and inducing apoptosis in EGFR-positive cancer cells, despite EGFR-targeted peptides not meeting expectations.
Area of Science:
- Oncology
- Molecular Biology
- Drug Delivery
Background:
- Epidermal growth factor receptor (EGFR) overexpression in solid tumors correlates with poor prognosis and treatment resistance.
- Overcoming drug resistance in EGFR-positive cancers remains a significant clinical challenge.
- Tumor-homing cell-penetrating peptides offer potential for targeted cancer therapy and improved drug delivery.
Purpose of the Study:
- To evaluate the anticancer potential of EGFR-targeted pro-apoptotic peptides (NRPD-KLAK-H, NRPD-CTMP4-H) and compare them with free His-tagged peptides (NRPD-H, KLAK-H, CTMP4-H).
- To investigate the role of His-tag modification in enhancing peptide internalization and overcoming drug resistance in EGFR-positive cancers.
Main Methods:
- MTT assays were used to determine cell viability and inhibitory concentrations (IC50).
- TUNEL assays were employed to assess apoptosis induction.
- Immunofluorescence microscopy was utilized to visualize and quantify peptide internalization into cancer cells.
Main Results:
- KLAK-H and NRPD-KLAK-H demonstrated significant anticancer effects, inhibiting A-549 cell growth with IC50 values of 33.3 µM and 40.9 µM, respectively.
- Apoptosis was induced by KLAK-H and NRPD-KLAK-H, as indicated by TUNEL assays.
- His-tag modification improved peptide internalization, with KLAK-H/NRPD-KLAK-H showing better uptake than CTMP4-H/NRPD-CTMP4-H.
Conclusions:
- His-tagged pro-apoptotic peptides, especially KLAK-H, show promise as potential cancer therapeutics due to enhanced cellular uptake and apoptosis induction.
- While EGFR-targeted peptides did not achieve the expected outcomes, His-tag modification is a viable strategy to improve the efficacy of pro-apoptotic peptides in cancer treatment.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Tagging and Fusion Proteins